BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/16/2023 9:52:18 AM | Browse: 167 | Download: 490
Publication Name World Journal of Gastroenterology
Manuscript ID 85137
Country Japan
Received
2023-04-13 11:18
Peer-Review Started
2023-04-13 11:18
To Make the First Decision
Return for Revision
2023-05-12 03:40
Revised
2023-05-14 08:24
Second Decision
2023-05-19 03:07
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2023-05-22 18:25
Articles in Press
2023-05-22 18:25
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-06-02 10:00
Publish the Manuscript Online
2023-06-16 09:52
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Recent advances in treatment of nodal and gastrointestinal follicular lymphoma
Manuscript Source Invited Manuscript
All Author List Takuya Watanabe
ORCID
Author(s) ORCID Number
Takuya Watanabe http://orcid.org/0000-0003-3820-0262
Funding Agency and Grant Number
Corresponding Author Takuya Watanabe, MD, PhD, Director, Director, Doctor, Doctor, Department of Internal Medicine and Gastroenterology, Watanabe Internal Medicine Aoyama Clinic, 1-2-21 Aoyama, Nishi-ku, Niigata-city 9502002, Japan. nabetaku@dia-net.ne.jp
Key Words Nodal and gastrointestinal follicular lymphoma; Antibody-based therapy; Bispecific antibody therapy; Phosphatidylinositol-3 kinase inhibitor; Epigenetic modulator; Chimeric antigen receptor-T cell therapy
Core Tip Primary gastrointestinal follicular lymphomas (FLs) have been increasingly detected in Japan, especially due to recent advances in small bowel endoscopy and increased opportunities for endoscopic examination and endoscopic diagnosis. Previously, many gastrolienal FL cases are detected at an early stage, however, the number of advanced cases is expected to increase in the future. This editorial provides an overview of the recent therapeutic advances in nodal FL, including antibody-targeted therapy, bispecific antibody therapy, epigenetic mutations, and chimeric antigen receptor T-cell therapy, and we also discuss future possibilities for gastroenterologists to treat gastrointestinal FL, especially in advanced cases.
Publish Date 2023-06-16 09:52
Citation Watanabe T. Recent advances in treatment of nodal and gastrointestinal follicular lymphoma. World J Gastroenterol 2023; 29(23): 3574-3594
URL https://www.wjgnet.com/1007-9327/full/v29/i23/3574.htm
DOI https://dx.doi.org/10.3748/wjg.v29.i23.3574
Full Article (PDF) WJG-29-3574-with-cover.pdf
Full Article (Word) WJG-29-3574.docx
Manuscript File 85137_Auto_Edited-LM.docx
Answering Reviewers 85137-Answering reviewers.pdf
Audio Core Tip 85137-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 85137-Conflict-of-interest statement.pdf
Copyright License Agreement 85137-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 85137-Language certificate.pdf
Peer-review Report 85137-Peer-review(s).pdf
Scientific Misconduct Check 85137-Bing-Chen YL-2.png
Scientific Editor Work List 85137-Scientific editor work list.pdf
CrossCheck Report 85137-CrossCheck report.pdf